SAM #412026

CDC Market Research for Clinical or Synthetic Specimen Matrices for Diagnostic Test Development

The Centers for Disease Control and Prevention (CDC) is seeking market input on acquiring clinical specimens or synthetic specimen matrices to support diagnostic test development and validation. - Government Buyer: - Department of Health and Human Services (HHS) - Centers for Disease Control and Prevention (CDC) - CDC Office of Acquisition Services - Purpose: - Market research for potential procurement of clinical specimens or synthetic specimen matrices - Supports the National Biodefense Strategy and pandemic preparedness - Products/Services Requested: - Clinical specimens or synthetic specimen matrices (no specific part numbers or quantities provided) - Notable Requirements: - Information gathering only; not a solicitation or award - No specific OEMs or vendors identified - Locations: - CDC Office of Acquisition Services, 1600 Clifton Road, Atlanta, GA 30333 (contracting office) - Place of performance: Georgia, ZIP 30341

Description

The primary goal of this RFI is to gather information regarding the acquisition of clinical specimens or synthetic specimen matrices for the development and validation of diagnostic tests. This initiative aligns with the National Biodefense Strategy and Implementation Plan, which outlines a broad national vision for enhancing pandemic preparedness and countering biological threats, including building specimen procurement capabilities to support rapid medical countermeasure development.

This RFI is for market research only and does not commit the Government to issue a solicitation, make an award, or pay any costs associated with responding to this RFI. The information submitted in all responses will be utilized to help the Government further define its requirements and develop acquisition strategies. All submitted information shall remain with the Government and will not be returned.

View original listing